This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Richard Bs Roden: Inventor of Small-Molecule RPN13 Inhibitors
Introduction
Richard Bs Roden is an inventor associated with Johns Hopkins University in Baltimore, Maryland. His patent work includes research into small-molecule inhibitors that target RPN13, a subunit of the 19S regulatory particle in the proteasome.
Latest Patents
Roden is named on one patent, 1 patent: “Small Molecule RPN13 Inhibitors with Antitumor Properties.” The patent describes compounds of formulas (I), (II), and (III), with substituents defined in the patent. These molecules act as proteasome inhibitors by binding to the RPN13 subunit. The disclosed compounds may be used in methods for treating conditions or diseases, including cancer, in mammals.
Career Highlights
Roden’s listed patent reflects work at the intersection of chemical research and potential cancer treatment. The invention focuses on targeting a specific proteasome component, offering a proposed approach for developing antitumor therapies.
Collaborations
Ravi K Anchoori is identified as Roden’s coworker and is associated with the patent work.
Conclusion
Richard Bs Roden’s patent contribution centers on small-molecule RPN13 inhibitors and their potential application in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile